Atypical antipsychotics in bipolar and schizoaffective disorders

E. S. Brown, N. R. Thomas, T. Carmody, S. Mahadi, V. A. Nejtek

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.

Original languageEnglish (US)
Pages (from-to)80-81
Number of pages2
JournalPharmacopsychiatry
Volume34
Issue number2
DOIs
StatePublished - Mar 28 2001

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Atypical antipsychotics in bipolar and schizoaffective disorders'. Together they form a unique fingerprint.

  • Cite this